Tower Research Capital LLC (TRC)

Position in SLGL — Sol-Gel Technologies Ltd.

CIK 1533421 NEW YORK, NY

Position in SLGL

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$7,414

+$191 QoQ

Shares Held

100

-86.4% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#22

of 24 holders

Holding Since

Jun 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,738,477 across 465 Biotechnology names. SLGL ranks #332 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	4,547	$4,218,570
2	BBIO	BridgeBio Pharma, Inc.	38,206	$2,845,582
3	ARWR	Arrowhead Pharmaceuticals, Inc.	34,537	$2,815,110
4	VRTX	Vertex Pharmaceuticals Inc / Ma	4,292	$2,131,964
5	MDGL	Madrigal Pharmaceuticals, Inc.	3,927	$2,108,602
6	AXSM	Axsome Therapeutics, Inc.	6,437	$1,575,584
7	INSM	INSMED Inc	10,927	$1,165,036
8	ROIV	Roivant Sciences Ltd.	32,746	$1,158,880

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,414	100	-98.6%	Shares	Defined	2026-08-11
2024-03-31	$7,223	7,371	+54.1%	Shares	Defined	2024-05-15
2023-12-31	$5,285	4,783	+91.5%	Shares	Defined	2024-02-13
2023-09-30	$4,069	2,497	-44.4%	Shares	Defined	2023-11-14
2023-06-30	$13,431	4,492	-5.4%	Shares	Defined	2023-08-14
2023-03-31	$18,422	4,748	+95.5%	Shares	Defined	2023-05-09
2022-12-31	$11,076	2,429	-57.0%	Shares	Defined	2023-02-10
2022-09-30	$28,327	5,643	+349.3%	Shares	Defined	2022-11-10
2022-06-30	$5,149	1,256	-11.7%	Shares	Other	2022-08-15
2021-12-31	$10,530	1,423	-5.2%	Shares	Defined	2022-02-14
2021-09-30	$15,010	1,501	+12408.3%	Shares	Defined	2021-11-15
2021-03-31	$148	12	-97.9%	Shares	Other	2021-05-17
2020-12-31	$5,501	562	-77.4%	Shares	Defined	2021-02-16
2020-09-30	$18,013	2,488	+48.6%	Shares	Defined	2020-11-16
2020-06-30	$14,987	1,674	—	Shares	Other	2020-08-13
No filing history on record for this holder in this stock.